Sequenom Launches $84M Public Stock Offering | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom has launched a common stock offering of 14 million shares priced at $6 per share.

The firm said Thursday that it expects gross proceeds of $84 million from the offering. Underwriters of the offering have a 30-day option to purchase up to an aggregate of 2,100,000 additional shares of common stock to cover overallotments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.